BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

425 related articles for article (PubMed ID: 31514446)

  • 1. Anti-Tumor Potential of IMP Dehydrogenase Inhibitors: A Century-Long Story.
    Naffouje R; Grover P; Yu H; Sendilnathan A; Wolfe K; Majd N; Smith EP; Takeuchi K; Senda T; Kofuji S; Sasaki AT
    Cancers (Basel); 2019 Sep; 11(9):. PubMed ID: 31514446
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inosine-5'-monophosphate dehydrogenase is required for mitogenic competence of transformed pancreatic beta cells.
    Metz S; Holland S; Johnson L; Espling E; Rabaglia M; Segu V; Brockenbrough JS; Tran PO
    Endocrinology; 2001 Jan; 142(1):193-204. PubMed ID: 11145582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanism of action of mycophenolate mofetil.
    Ransom JT
    Ther Drug Monit; 1995 Dec; 17(6):681-4. PubMed ID: 8588241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune Response-Dependent Assembly of IMP Dehydrogenase Filaments.
    Calise SJ; Abboud G; Kasahara H; Morel L; Chan EKL
    Front Immunol; 2018; 9():2789. PubMed ID: 30555474
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A putative role for inosine 5' monophosphate dehydrogenase (IMPDH) in Leishmania amazonensis programmed cell death.
    Pitaluga AN; Moreira ME; Traub-Csekö YM
    Exp Parasitol; 2015 Feb; 149():32-8. PubMed ID: 25499513
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The structure of inosine 5'-monophosphate dehydrogenase and the design of novel inhibitors.
    Sintchak MD; Nimmesgern E
    Immunopharmacology; 2000 May; 47(2-3):163-84. PubMed ID: 10878288
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Consequences of IMP dehydrogenase inhibition, and its relationship to cancer and apoptosis.
    Jayaram HN; Cooney DA; Grusch M; Krupitza G
    Curr Med Chem; 1999 Jul; 6(7):561-74. PubMed ID: 10390601
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of inosine monophosphate dehydrogenase type I and type II isoforms in human lymphocytes.
    Jain J; Almquist SJ; Ford PJ; Shlyakhter D; Wang Y; Nimmesgern E; Germann UA
    Biochem Pharmacol; 2004 Feb; 67(4):767-76. PubMed ID: 14757177
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IMP dehydrogenase basal activity in MOLT-4 human leukaemia cells is altered by mycophenolic acid and 6-thioguanosine.
    Vethe NT; Bremer S; Bergan S
    Scand J Clin Lab Invest; 2008; 68(4):277-85. PubMed ID: 18609073
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inosine 5'-monophosphate dehydrogenase inhibition by mycophenolic acid impairs maturation and function of dendritic cells.
    Dubsky PC; Friedl J; Stift A; Bachleitner-Hofmann T; Jakesz R; Gnant MF; Weigel G
    Clin Chim Acta; 2006 Feb; 364(1-2):139-47. PubMed ID: 16051207
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibitors of inosine 5'-monophosphate dehydrogenase as emerging new generation antimicrobial agents.
    Juvale K; Shaik A; Kirubakaran S
    Medchemcomm; 2019 Aug; 10(8):1290-1301. PubMed ID: 31534651
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nucleoside and non-nucleoside IMP dehydrogenase inhibitors as antitumor and antiviral agents.
    Franchetti P; Grifantini M
    Curr Med Chem; 1999 Jul; 6(7):599-614. PubMed ID: 10390603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inosine 5'-monophosphate dehydrogenase inhibitors for the treatment of autoimmune diseases.
    Ratcliffe AJ
    Curr Opin Drug Discov Devel; 2006 Sep; 9(5):595-605. PubMed ID: 17002220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of Inosine Monophosphate Dehydrogenase Activity Assay to Determine the Specificity of PARP-1 Inhibitors.
    Anthony S; Peterson JR; Ji Y
    Methods Mol Biol; 2017; 1608():337-342. PubMed ID: 28695520
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IMP/GTP balance modulates cytoophidium assembly and IMPDH activity.
    Keppeke GD; Chang CC; Peng M; Chen LY; Lin WC; Pai LM; Andrade LEC; Sung LY; Liu JL
    Cell Div; 2018; 13():5. PubMed ID: 29946345
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inosine 5'-Monophosphate Dehydrogenase (IMPDH) as a Potential Target for the Development of a New Generation of Antiprotozoan Agents.
    Fotie J
    Mini Rev Med Chem; 2018; 18(8):656-671. PubMed ID: 27334467
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The determination and clinical application of inosine 5’-monophosphate dehydrogenase activity].
    Liu FY; Qiu XY; Jiao Z
    Yao Xue Xue Bao; 2016 Nov; 51(11):1666-73. PubMed ID: 29908108
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of Tmolt4 leukemia cell death by 3,3-disubstituted-6,6-pentamethylene-1,5-diazabicyclo[3.1.0]hexane-2-4-diones: specificity for type II inosine 5'-monophasphate dehydrogenase.
    Barnes BJ; Izydore RA; Eakin AE; Hall IH
    J Pharmacol Exp Ther; 2001 Aug; 298(2):790-6. PubMed ID: 11454943
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cellular IMPDH enzyme activity is a potential target for the inhibition of Chikungunya virus replication and virus induced apoptosis in cultured mammalian cells.
    Khan M; Dhanwani R; Patro IK; Rao PV; Parida MM
    Antiviral Res; 2011 Jan; 89(1):1-8. PubMed ID: 21070810
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Crystal structure at 2.4 A resolution of Borrelia burgdorferi inosine 5'-monophosphate dehydrogenase: evidence of a substrate-induced hinged-lid motion by loop 6.
    McMillan FM; Cahoon M; White A; Hedstrom L; Petsko GA; Ringe D
    Biochemistry; 2000 Apr; 39(15):4533-42. PubMed ID: 10758003
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.